Chapter Two - The Birth of a Chemical Giant

CHAPTER TWO

The Birth of a Chemical Giant

THE BREAKTHROUGH CAME in 1897.

A young chemist named Felix Hoffmann was working in Bayer’s lab, trying to stabilize a compound his boss thought might help with inflammation. The result was acetylsalicylic acid. A cleaner, more stable version of salicylic acid, which had been used for centuries to treat pain and fever.

Bayer named it Aspirin.

They didn’t just make it. They branded it. Promoted it. Pushed it. And it exploded. Aspirin became one of the first blockbuster drugs in history. It was cheap, effective, and everywhere. By 1910, Bayer was shipping it worldwide. The company wasn’t just riding the wave of modern medicine. It was shaping it.

Germany was at the center of chemical innovation. And Bayer was becoming its crown jewel.

They expanded rapidly with more labs, more factories, and more scientists. They built a global distribution network. They started filing trademarks, fighting patents, and defending their name. Aspirin became a brand, a symbol, and eventually, a monopoly.

But Bayer wasn’t finished.

They kept chasing the next discovery. The same year Hoffmann synthesized aspirin, he modified another compound, this one derived from morphine. Bayer called it Heroin. It was marketed as a non-addictive painkiller and cough suppressant.

It was sold in bottles. Given to children. Advertised in medical journals.

And Bayer owned the rights.

The company wasn’t just growing. It was changing. From dyes to drugs. From labs to lives. From chemistry to commerce. Bayer had found the formula: discover, patent, market, dominate.

By the early 20th century, they weren’t just another German manufacturer.

They were a chemical empire in the making.